We would love to hear your thoughts about our site and services, please take our survey here.
Thanks all. I will wait on tenterhooks like everyone else, expecting a rocket but fear a sparkler.
sorry 'we'
do have a date for this October update?
Oh no Motley Fool giving it a buy that's going to put the kiss of death on it.
its not a good read to hear that this lab has made a mess of its Covid testing esp as it was Govt accredited lab as well.
agree , I think the spring is tightening on this stock now.
the fact the Directors have bought in again absolutely shows that believe this hiccup will be rectified. I actually feel more comfortable now about my investment than I did before, at least the BOD now know what is on the table and what to address. I just wish that I had had the balls (and money) to buy in again last week at the low unfortunately I am heavily invested in the £1 range. I think there was a golden opportunity missed there.
I'm sure the board will be working behind the scenes to reassure the major shareholders that the questions raised in the CRL are rectifiable and hopefully stop the rot. If they can do this we may see further buying at these low prices.
...bottom drawer it is, my drawer is getting full of stinkers. Worse than the dirty laundry basket.
its a blood bath out there.
been here before with a CRL, looking at another 12 months IMO now.
...death and taxes.
'Dead cert' no such thing except death and taxes.
I cant tell you how you much money I have lost over the years to dead certs.
GLA
7am RNS?
I think peoples immediate expectations if successfully approved are somewhat over optimistic. I think a modest rise and and then settle down again. The downside in my opinion would be far worse. I'm in for the long haul (IF approved) GLA.
it wont be any where near £3 with FDA approval, as stated below it has to sell first to gain SP value, FDA approval only open the shop door.
nothing is a given with the FDA. I work in Biotech and have been bitten many times with own company drugs and others, however this is mainly a technology so not sure what to expect.
Nice RNS
Ron I absolutely agree with your comments.. Despite really positive and exciting news over the last 12 months- and there has been some great news, shareholder value has been sadly neglected and left behind. I agree there is an obsession with Mkt Cap. We've all witnessed some meteoric SP rises in companies with very little substance but for whatever reason this companies SP has been left behind despite having a solid core business and a nice sideline of Covid activity backed by Govt contracts. Something doesn't sit right and I don't want to keep reading about the smug Board feathering their nests anymore.
Stonk yes but you could also have bought many times throughout the year at lower prices. Was it almost 15/16p a month ago? Yes I understand the FOMO but this continual 'is it going to drop today' is and has been tedious, clearly earlier in the year it was going to be a long drawn out affair and the stock has been a day/weekly trading share, maybe not so now.
couple of big buys landed on deck.